Departamento de Psiquiatría, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Grupo de Investigación en Psiquiatría (GIPSI), Departamento de Psiquiatría, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Rev Colomb Psiquiatr (Engl Ed). 2022 Apr-Jun;51(2):133-145. doi: 10.1016/j.rcpeng.2020.10.003. Epub 2022 Jun 15.
Lithium treatment of bipolar disorder (BD) has been associated with less cognitive impairment and fewer changes in structural brain anatomy compared to other treatments. However, the studies are heterogeneous and few assess whether these effects are related. The objective of this study was to evaluate and relate cognitive performance and structural neuroanatomy in patients treated with and without lithium.
Cross-sectional study that included 48 subjects with BD-I, of which 22 were treated with lithium and 26 without lithium. Performance was assessed on Wechsler III (WAIS III), TMT A and B (Trial Making Test) neuropsychological tests, California verbal learning test (CVLT), Rey complex figure test and Wisconsin card sorting test. Brain structures obtained by magnetic resonance imaging (MRI) were evaluated. The standardised mean difference (SMD) between both groups was calculated, adjusted for confounding variables using a propensity score, and the Spearman correlation coefficient (ρ) was used to assess the relationship between cognitive performance and neuroanatomical regions.
Compared to the group without lithium, the group with lithium had fewer perseverative errors in the Wisconsin test (SMD = -0.69) and greater left and right cortical areas (SMD = 0.85; SMD = 0.92); greater surface area in the left anterior cingulate (SMD = 1.32), right medial orbitofrontal cortex (SMD = 1.17), right superior frontal gyrus (SMD = 0.82), and right and left precentral gyrus (SMD = 1.33; SMD = 0.98); greater volume of the right amygdala (SMD = 0.57), right hippocampus (SMD = 0.66), right putamen (SMD = 0.87) and right thalamus (SMD = .67). In the lithium group, a correlation was found with these errors and the thickness of the left precentral gyrus (ρ = -0.78), the volume of the right thalamus (ρ = -0.44), and the right amygdala (ρ = 0.6).
The lithium group had better cognitive flexibility and greater dimension in some frontal and subcortical cortical regions. Furthermore, there was a moderate to high correlation between performance in this executive function and the thickness of the right precentral gyrus, and the volumes of the thalamus and the right amygdala. These findings could suggest a neuroprotective effect of lithium.
与其他治疗方法相比,锂治疗双相情感障碍(BD)与认知障碍较少和结构脑解剖变化较少有关。然而,这些研究存在异质性,很少有研究评估这些影响是否相关。本研究的目的是评估和比较锂治疗和未治疗的患者的认知表现和结构神经解剖。
这是一项横断面研究,纳入了 48 名 BD-I 患者,其中 22 名接受锂治疗,26 名未接受锂治疗。使用韦氏智力测验 III(WAIS III)、TMT A 和 B(连线测验)神经心理学测验、加利福尼亚语言学习测验(CVLT)、 Rey 复杂图形测验和威斯康星卡片分类测验评估表现。使用磁共振成像(MRI)获得脑结构。计算两组间的标准化均数差(SMD),使用倾向评分调整混杂变量,并使用 Spearman 相关系数(ρ)评估认知表现与神经解剖区域之间的关系。
与未用锂治疗的组相比,用锂治疗的组在威斯康星测试中的持续错误更少(SMD=-0.69),左、右皮质区更大(SMD=0.85;SMD=0.92);左前扣带回(SMD=1.32)、右内侧眶额皮质(SMD=1.17)、右额上回(SMD=0.82)和右、左中央前回(SMD=1.33;SMD=0.98)的表面积更大;右杏仁核(SMD=0.57)、右海马(SMD=0.66)、右壳核(SMD=0.87)和右丘脑(SMD=0.67)的体积更大。在锂治疗组中,发现这些错误与左中央前回的厚度(ρ=-0.78)、右丘脑的体积(ρ=-0.44)和右杏仁核的体积(ρ=0.6)之间存在相关性。
锂治疗组在一些额叶和皮质下皮质区域具有更好的认知灵活性和更大的维度。此外,在这项执行功能的表现与右中央前回的厚度以及丘脑和右杏仁核的体积之间存在中度到高度的相关性。这些发现可能表明锂具有神经保护作用。